---
title: "SYNERGY: Tofisopam has obtained the drug registration certificate in South Korea"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241956982.md"
description: "According to the Zhitong Finance APP, SYNERGY announced that the company recently received the drug registration certificate for tolvaptan from the Ministry of Food and Drug Safety (MFDS) of South Korea. Tolvaptan is an oral anticoagulant primarily used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment or prevention of deep vein thrombosis and pulmonary embolism"
datetime: "2025-05-27T07:58:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241956982.md)
  - [en](https://longbridge.com/en/news/241956982.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241956982.md)
---

# SYNERGY: Tofisopam has obtained the drug registration certificate in South Korea

According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that the company recently received the drug registration certificate for tolvaptan from the Ministry of Food and Drug Safety (MFDS) of South Korea. Tolvaptan is an oral anticoagulant primarily used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment or prevention of deep vein thrombosis and pulmonary embolism

### Related Stocks

- [300636.CN](https://longbridge.com/en/quote/300636.CN.md)

## Related News & Research

- [Chemtrade Logistics Holds Guidance Amid Commodity Swings](https://longbridge.com/en/news/286831060.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [Alibaba unveils new Qwen model, custom chips in bid to become China’s AI factory](https://longbridge.com/en/news/287044112.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [JPMorgan lowers 2026 gold forecast, still sees rally towards $6,000 on renewed demand](https://longbridge.com/en/news/286715908.md)